Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate

Vaccine

Volumn 28, Issue 17, 2010, Pages 3030-3037

  Kelly, Eileen P ^a   Puri, Beena ^b   Sun, Wellington ^a   Falgout, Barry ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Dengue virus; Infectious clone; Vaccine virus mutation analysis

Indexed keywords

COMPLEMENTARY DNA; DENGUE VACCINE; VIRUS PROTEIN;

AEDES ALBOPICTUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 4; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN;

AEDES; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DENGUE; DENGUE VACCINES; DENGUE VIRUS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DOGS; HUMAN EXPERIMENTATION; HUMANS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MONKEY DISEASES; MUTATION, MISSENSE; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VACCINES, ATTENUATED; VIRULENCE;

EID: 77949653562     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.084     Document Type: Article

References (53)

1. World Health Organization. Dengue and dengue hemorrhagic fever. Fact sheet no. 117 (2002), World Health Organization, Geneva, Switzerland
2. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11 (1998) 480-496
3. Halstead S.B. Antibody, macrophages, dengue virus infection, shock and hemorrhage: a pathogenic cascade. Rev Inf Dis 11 Suppl. 4 (1989) S830-S839
4. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Inf Dis 181 (2000) 2-9
5. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Inf Dis 185 (2002) 1213-1221
6. Mongkolsapaya J., Duangchinda T., Dejnirattisai W., Vasanawathana S., Avirutnan P., Jairungsri A., et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol 176 (2006) 3821-3829
7. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organization, expression and replication. Ann Rev Microbiol 44 (1990) 649-688
8. Wengler G., Bradley D.W., Collett M.S., Heinz F.X., Schlesinger R.W., and Strauss J.H. Flaviviridae. In: Murphy F.A., Fauquet C.M., Bishop D.H.L., Ghabrial S.A., Jarvis A.W., Martelli G.P., Mayo M.A., and Summers M.D. (Eds). Virus taxonomy: the classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses. Vienna: Springer-Verlag (1995) 415-427
9. Marchette N.J., Dubois D.R., Larson L.K., Summers P.L., Kraiselburd E.G., Gubler D.J., et al. Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine I. Pre-clinical studies. Am J Trop Med Hyg 43 (1990) 212-218
10. Hoke Jr. C.H., Malinoski F.J., Eckels K.H., Scott R.M., Dubois D.R., Summers P.L., et al. Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine II. Safety and immunogenicity in humans. Am J Trop Med Hyg 43 (1990) 219-226
11. Sun W., Edelman R., Kanesa-Thasan N., Eckels K.H., Putnak J.R., King A.D., et al. Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. Am J Trop Med Hyg 69 Suppl. 6 (2003) 24-31
12. Eckels K.H., Dubois D.R., Putnak R., Vaughn D.W., Innis B.L., Henchal E.A., et al. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys. Am J Trop Med Hyg 69 Suppl. 6 (2003) 12-16
13. Mandl C.W., Heinz F.X., Puchhammer-Stockl E., and Kunz C. Sequencing the termini of capped viral RNA by 5′-3′ ligation and PCR. Biotechniques 10 (1991) 484-486
14. Falgout B., Chanock R., and Lai C.J. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol 63 (1989) 1852-1860
15. Valle R.P., and Wickner R.B. Elimination of L-A double-stranded RNA virus of Saccharomyces cerevisiae by expression of gag and gag-pol from an L-A cDNA clone. J Virol 67 (1993) 2764-2771
16. Zeng L., Falgout B., and Markoff L. Identification of specific nucleotide sequences within the conserved 3′-SL in the dengue type 2 virus genome required for replication. J Virol 2 (1998) 7510-7522
17. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375 (1995) 291-298
18. Modis Y., Ogata S., Clements D., and Harrison S.C. A ligand-binding pocket in the dengue envelope glycoproteins. Proc Natl Acad Sci USA 100 (2003) 6986-6991
19. Modis Y., Ogata S., Clements D., and Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79 (2005) 1223-1231
20. Bressanelli S., Stiasny K., Allison S.L., Stura E.A., Duquerroy S., Lescar J., et al. Structure of a flavivirus envelope glycoprotein in its low pH-induced membrane fusion conformation. EMBO J 23 (2004) 728-738
21. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 (2004) 313-319
22. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J.H., Baker T.S., et al. Conformational changes of the flavivirus E glycoprotein. Structure 12 (2004) 1607-1618
23. Pugachev K.V., Guirakhoo F., Ocran S.W., Mitchell F., Parsons M., Penal C., et al. High fidelity of yellow fever virus RNA polymerase. J Virol 78 (2004) 1032-1038
24. Tang W.F., Eshita Y., Tadano M., Moria K., and Makino Y. Molecular Basis for adaptation of a chimeric dengue type-4/Japanese encephalitis virus to Vero cells. Microbiol Immunol 49 (2005) 285-294
25. Lee E., Weir R.C., and Dalgarno L. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology 232 (1997) 281-290
26. Duarte dos Santos C.N., Frenkiel M.P., Courageot M.P., Rocha C.F., Vazeille-Falcoz M.C., Wien M.W., et al. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. Virology 274 (2000) 292-308
27. Huang C.Y.H., Butrapet S., Pierro D.J., Chang G.J.J., Hunt A.R., Bhamarapravati N., et al. Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol 74 (2000) 3020-3028
28. Monath T.P., Arroyo J., Levenbook I., Zhang Z.X., Catalan J., Draper K., et al. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 76 (2002) 1932-1943
29. Guirakhoo F., Zhang Z., Myers G., Johnson B.W., Pugachev K., Nichols R., et al. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. J Virol 78 (2004) 9998-10008
30. Zulueta A., Martin J., Hermida L., Alvarez M., Valdes I., Prado I., et al. Amino acid changes in the recombinant dengue 3 envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res 121 (2006) 65-73
31. Hiramatsu K., Tadano M., Men R., and Lai C.J. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 224 (1996) 437-445
32. Holzmann H., Heinz F.X., Mandl C.W., Guirakhoo F., and Kunz C. A single amino acid substitution in the envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol 64 (1990) 5156-5159
33. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., and Chen W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito by not mammalian cells. J Virol 78 (2004) 378-388
34. Crooks A.J., Lee J.M., Easterbrook L.M., Timofeev A.V., and Stephenson J.R. The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J Gen Virol 75 (1994) 3453-3460
35. Mackenzie J.M., Jones M.K., and Young P.R. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220 (1996) 232-240
36. Westaway E.G., Mackenzie J.M., Kenney M.T., Jones M.K., and Khromykh A.A. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA and of NS2B with NS3 in virus-induced membrane structures. J Virol 71 (1997) 6650-6661
37. Muylaert I.R., Galler R., and Rice C.M. Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol 71 (1997) 291-298
38. Schlesinger J.J., Brandriss M.W., Putnak J.R., and Walsh E.E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 non-structural glycoprotein NS1. J Gen Virol 71 (1990) 593-599
39. Libraty D.H., Young P.R., Pickering D., Endy T.P., Kalayanarooj S., Green S., et al. High circulating levels of the dengue virus nonstructural protein NS1 in dengue illness correlate with the development of dengue hemorrhagic fever. J Inf Dis 186 (2002) 1165-1168
40. Pryor M.J., and Wright P.J. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194 (1993) 769-780
41. Butrapet S., Huang C.Y.H., Pierro D.J., Bhamarapravati N., Gubler D.J., and Kinney R.M. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′noncoding region and nonstructural proteins 1 and 3. J Virol 74 (2000) 3011-3019
42. Blaney Jr. J.E., Manipon G.G., Firestone C.Y., Johnson D.H., Hanson C.T., Murphy B.R., et al. Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells. Vaccine 21 (2003) 4317-4327
43. Blaney Jr. J.E., Hanson C.T., Firestone C.Y., Hanley K.A., Murphy B.R., and Whitehead S.S. Genetically modified, live attenuated dengue virus type 3 vaccine candidates. Am J Trop Med Hyg 71 (2004) 811-821
44. Miller S., Sparacio S., and Bartenschlager R. Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B. J Biol Chem 281 (2006) 8854-8863
45. Umareddy I., Chao A., Sampath A., Gu F., and Vasudevan S.G. Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol 87 (2006) 2605-2614
46. Munoz-Jordan J.L., Laurent-Rolle M., Ashour J., Martinez-Sobrido L., Ashok M., Lipkin W.I., et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79 (2005) 8004-8013
47. Koonin E.V. Computer-assisted identification of a putative methyl-transferase domain in NS5 protein of flaviviruses and lambda 2 protein of reovirus. J Gen Virol 74 (1993) 733-740
48. Egloff M.P., Benarroch D., Selisko B., Romette J.L., and Canard B. An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 21 (2002) 2757-2768
49. Bressanelli S., Tomei L., Roussel A., Incitti I., Vitale R.L., Mathieu M., et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 96 (1999) 13034-13039
50. Bressanelli S., Tomei L., Rey F.A., and De Francesco R. Structural analysis of the hepatitits C virus RNA polymerase in complex with ribonucleotides. J Virol 76 (2002) 3482-3492
51. Kao C.C., Singh P., and Ecker D. De novo initiation of viral RNA-dependent RNA synthesis. Virology 287 (2001) 251-260
52. Selisko B., Dutartre H., Guillemot J.C., Debarnot C., Benarroch D., Khromykh A., et al. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases. Virology 351 (2006) 145-158
53. Watanabe K., Yoshioka K., Yano M., Ishigami M., Ukai K., Ito H., et al. Mutations in the nonstructural region 5B of Hepatitis C virus genotype 1b: their relation to viral load, response to interferon and the nonstructural region 5A. J Med Virol 75 (2005) 504-512